☰

Sara Nasser, Ph.D. - Publications

Affiliations: 
2008 Computer Science University of Nevada, Reno, Reno, NV, United States 
Area:
Computer Science, Bioinformatics Biology
Tree Info Similar researchers PubMed Report error

37 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2024 Skerget S, Penaherrera D, Chari A, Jagannath S, Siegel DS, Vij R, Orloff G, Jakubowiak A, Niesvizky R, Liles D, Berdeja J, Levy M, Wolf J, Usmani SZ, Christofferson AW, ... Nasser S, et al. Comprehensive molecular profiling of multiple myeloma identifies refined copy number and expression subtypes. Nature Genetics. PMID 39160255 DOI: 10.1038/s41588-024-01853-0  0.346
2019 Berens ME, Sood A, Barnholtz-Sloan JS, Graf JF, Cho S, Kim S, Kiefer J, Byron SA, Halperin RF, Nasser S, Adkins J, Cuyugan L, Devine K, Ostrom Q, Couce M, et al. Multiscale, multimodal analysis of tumor heterogeneity in IDH1 mutant vs wild-type diffuse gliomas. Plos One. 14: e0219724. PMID 31881020 DOI: 10.1371/Journal.Pone.0219724  0.381
2019 Mueller S, Jain P, Liang WS, Kilburn L, Kline C, Gupta N, Panditharatna E, Magge SN, Zhang B, Zhu Y, Crawford JR, Banerjee A, Nazemi K, Packer RJ, Petritsch CK, ... ... Nasser S, et al. A pilot precision medicine trial for children with diffuse intrinsic pontine glioma - PNOC003: a report from the Pacific Pediatric Neuro-Oncology Consortium. International Journal of Cancer. PMID 30861105 DOI: 10.1002/Ijc.32258  0.382
2019 Skerget S, Christofferson A, Nasser S, Legendre C, Yesil J, Auclair D, Lonial S, Keats J. Identification and Molecular Characterization of High-Risk Multiple Myeloma Patients from the MMRF CoMMpass Study at Diagnosis and Progression Clinical Lymphoma, Myeloma & Leukemia. 19. DOI: 10.1016/J.Clml.2019.09.009  0.309
2018 Penaherrera D, Skerget S, Christofferson A, Aldrich J, Nasser S, Legendre C, Boateng M, Cuyugan L, Adkins J, Tassone E, Yesil J, Auclair D, Liang W, Lonial S, Keats JJ. Development and Validation of a High Risk Multiple Myeloma Gene Expression Index from RNA Sequencing: An Mmrf Commpass Analysis Blood. 132: 1895-1895. DOI: 10.1182/Blood-2018-99-119610  0.317
2018 Nasser S, Aldrich J, Penaherrera D, Christofferson A, Legendre C, Yesil J, Auclair D, Liang W, Lonial S, Skerget S, Keats JJ. An Integrated Genomics Analysis Identifies Recurrent Gain- and Loss-of-Function Events and in Distinct Subtypes of Multiple Myeloma Blood. 132: 113-113. DOI: 10.1182/Blood-2018-99-119354  0.425
2018 Skerget S, Penaherrera D, Aldrich J, Nasser S, Christofferson A, Legendre C, Boateng M, Cuyugan L, Adkins J, Tassone E, Yesil J, Auclair D, Liang W, Lonial S, Keats JJ. Analysis of Sequential Patient Samples from the Mmrf Commpass Study Identifies a High Risk Progression Phenotype Blood. 132: 111-111. DOI: 10.1182/Blood-2018-99-118617  0.44
2018 Skerget S, Christofferson A, Nasser S, Aldrich J, Penaherrera D, Legendre C, Boateng M, Cuyugan L, Adkins J, Tassone E, Yesil J, Auclair D, Liang W, Keats JJ. Abstract 3006: Molecular characterization of baseline and serial multiple myeloma patients from the MMRF CoMMpass study Cancer Research. 78: 3006-3006. DOI: 10.1158/1538-7445.Am2018-3006  0.452
2017 Byron SA, Tran NL, Halperin RF, Phillips JJ, Kuhn JG, de Groot JF, Colman H, Ligon KL, Wen PY, Cloughesy TF, Mellinghoff IK, Butowski N, Taylor J, Clarke JL, Chang SM, ... ... Nasser S, et al. Prospective feasibility trial for genomics-informed treatment in recurrent and progressive glioblastoma. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. PMID 29074604 DOI: 10.1158/1078-0432.Ccr-17-0963  0.354
2017 Liang WS, Hendricks W, Kiefer J, Schmidt J, Sekar S, Carpten J, Craig DW, Adkins J, Cuyugan L, Manojlovic Z, Halperin RF, Helland A, Nasser S, Legendre C, Hurley LH, et al. Integrated genomic analyses reveal frequent TERT aberrations in acral melanoma. Genome Research. 27: 524-532. PMID 28373299 DOI: 10.1101/Gr.213348.116  0.388
2017 Nasser S, Christofferson A, Legendre C, Aldrich J, Benard B, Yesil J, Auclair D, Liang W, Lonial S, Keats J. Comprehensive Identification of Fusion Transcripts in Multiple Myeloma: An Mmrf Commpass Analysis Blood. 130: 61-61. DOI: 10.1182/Blood.V130.Suppl_1.61.61  0.394
2017 Benard B, Christofferson A, Legendre C, Aldrich J, Nasser S, Yesil J, Auclair D, Liang W, Lonial S, Keats JJ. FGFR3 Mutations Are an Adverse Prognostic Factor in Patients with t(4;14)(p16;q32) Multiple Myeloma: An Mmrf Commpass Analysis Blood. 130: 3027-3027. DOI: 10.1182/Blood.V130.Suppl_1.3027.3027  0.35
2017 Skerget S, Benard B, Christofferson A, Legendre C, Aldrich J, Nasser S, Yesil J, Auclair D, Liang W, Lonial S, Keats JJ. A Molecular Analysis of Cereblon-Related Immunomodulatory Drug Resistance in Commpass Multiple Myeloma Patients Blood. 130: 1754-1754. DOI: 10.1182/Blood.V130.Suppl_1.1754.1754  0.37
2017 Kiefer J, Nasser S, Graf J, Kodira C, Ginty F, Newberg L, Sood A, Berens ME. Abstract 3589: A systematic approach toward gene annotation of the hallmarks of cancer Cancer Research. 77: 3589-3589. DOI: 10.1158/1538-7445.Am2017-3589  0.414
2017 Liang WS, Hendricks W, Kiefer J, Schmidt J, Sekar S, Carpten J, Craig DW, Adkins J, Cuyugan L, Manojlovic Z, Halperin RF, Helland A, Nasser S, Legendre C, Hurley LH, et al. Abstract 3389: Integrated genomic analyses reveal frequentTERTaberrations in acral melanoma Cancer Research. 77: 3389-3389. DOI: 10.1158/1538-7445.Am2017-3389  0.308
2016 Bryce AH, Borad MJ, Egan JB, Condjella RM, Liang WS, Fonseca R, McCullough AE, Hunt KS, Ritacca NR, Barrett MT, Patel MD, Young SW, Silva AC, Ho TH, Halfdanarson TR, ... ... Nasser S, et al. Comprehensive Genomic Analysis of Metastatic Mucinous Urethral Adenocarcinoma Guides Precision Oncology Treatment: Targetable EGFR Amplification Leading to Successful Treatment With Erlotinib. Clinical Genitourinary Cancer. PMID 28057415 DOI: 10.1016/J.Clgc.2016.11.001  0.324
2016 Borad MJ, Egan JB, Condjella RM, Liang WS, Fonseca R, Ritacca NR, McCullough AE, Barrett MT, Hunt KS, Champion MD, Patel MD, Young SW, Silva AC, Ho TH, Halfdanarson TR, ... ... Nasser S, et al. Clinical Implementation of Integrated Genomic Profiling in Patients with Advanced Cancers. Scientific Reports. 6: 25. PMID 28003660 DOI: 10.1038/S41598-016-0021-4  0.419
2016 Craig DW, Nasser S, Corbett R, Chan SK, Murray L, Legendre C, Tembe W, Adkins J, Kim N, Wong S, Baker A, Enriquez D, Pond S, Pleasance E, Mungall AJ, et al. A somatic reference standard for cancer genome sequencing. Scientific Reports. 6: 24607. PMID 27094764 DOI: 10.1038/Srep24607  0.4
2016 Basu GD, White T, LoBello JR, Lau KR, Syring M, Krishnan S, Gonzalez L, Royce T, Kurdoglu A, Halbert MJ, Kiefer J, Cherni I, Aldrich J, Izatt T, Russell M, ... Nasser S, et al. ARID1A alterations in gastrointestinal cancers as therapeutic opportunities. Journal of Clinical Oncology. 34: 671-671. DOI: 10.1200/Jco.2016.34.4_Suppl.671  0.421
2016 McEachron TA, Zabokrtsky KB, Sassoon AF, Nasser S, Izatt T, Garner CP, Craig DW, Carpten JD, Sender LS. Abstract PR06: Precision medicine for newly diagnosed and refractory/recurrent pediatric cancer patients: Lessons learned from “N=1” studies Clinical Cancer Research. 22. DOI: 10.1158/1557-3265.Pmsclingen15-Pr06  0.437
2016 Getz JE, Teoh DB, Nasser S, Legendre CR, Tembe W, Yellapantula V, Ahearn ME, Gomez CR, Jorda M, Wong SM, Pegram MD, Carpten JD, Baumbach-Reardon LL. Abstract C54: High caveolin-1 expression in a cohort of African American women with triple-negative breast cancer Cancer Epidemiology, Biomarkers & Prevention. 25. DOI: 10.1158/1538-7755.Disp15-C54  0.313
2016 Krishnan S, Basu GD, Gonzalez-Malerva L, Royce T, White T, Lobello JR, King A, Lau K, Kurdoglu A, Halbert M, Kiefer J, Cherni I, Aldrich J, Izatt T, Russell M, ... Nasser S, et al. Abstract 4493: Germline findings in targeted tumor sequencing using matched normal DNA Cancer Research. 76: 4493-4493. DOI: 10.1158/1538-7445.Am2016-4493  0.435
2015 White T, LoBello JR, Kurdoglu A, Krishnan S, Gonzalez L, Royce T, Kiefer J, Cherni I, Aldrich J, Izatt T, Russell M, Nasser S, Carpten JD, Craig DW, Demeure MJ. Alterations in the cell cycle checkpoint pathway in breast cancer. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. 33: 126. PMID 28147798 DOI: 10.1200/Jco.2015.33.28_Suppl.126  0.37
2015 Getz JE, Teoh DB, Nasser S, Waibhav T, Christophe LR, Yellapantula V, Ahearn ME, Gomez CR, Jorda M, Pegram MD, Carpten JD, Baumbach LL. Abstract A74: Differential Wnt signaling in African American and Caucasian women with triple-negative breast cancer Cancer Epidemiology, Biomarkers & Prevention. 24. DOI: 10.1158/1538-7755.Disp14-A74  0.353
2014 Borad MJ, Champion MD, Egan JB, Liang WS, Fonseca R, Bryce AH, McCullough AE, Barrett MT, Hunt K, Patel MD, Young SW, Collins JM, Silva AC, Condjella RM, Block M, ... ... Nasser S, et al. Integrated genomic characterization reveals novel, therapeutically relevant drug targets in FGFR and EGFR pathways in sporadic intrahepatic cholangiocarcinoma. Plos Genetics. 10: e1004135. PMID 24550739 DOI: 10.1371/Journal.Pgen.1004135  0.451
2014 Salhia B, Kiefer J, Ross JT, Metapally R, Martinez RA, Johnson KN, DiPerna DM, Paquette KM, Jung S, Nasser S, Wallstrom G, Tembe W, Baker A, Carpten J, Resau J, et al. Integrated genomic and epigenomic analysis of breast cancer brain metastasis. Plos One. 9: e85448. PMID 24489661 DOI: 10.1371/Journal.Pone.0085448  0.391
2014 Salhia B, Kiefer J, Ross JTD, Metapally R, Martinez RA, Johnson KN, DiPerna DM, Paquette KM, Jung S, Nasser S, Wallstrom G, Tembe W, Baker A, Carpten J, Resau J, et al. Validation of ATAD2 and cMYC Copy Number and Gene Expression in Breast Brain Metastasis (BBM, n = 42) and Early-Stage Primary Breast Cancer Samples (n = 50). Plos One. DOI: 10.1371/Journal.Pone.0085448.G005  0.317
2014 Bryce AH, Borad MJ, Condjella RM, Egan JB, Champion MD, Hunt KS, McWilliams RR, McCullough AE, Kurdoglu A, Aldrich J, Izatt T, Nasser S, Christoforides A, Phillips L, Liang WS, et al. A study of real-time CLIA-enabled whole genome tumor sequencing: Results for testicular cancer and sarcomatoid RCC. Journal of Clinical Oncology. 32: 463-463. DOI: 10.1200/Jco.2014.32.4_Suppl.463  0.46
2014 DiPerna D, Gooden GC, Hjelm B, Nasser S, LoBello J, Watanabe A, Salhia B. Abstract 5158: The H3K9 demethyltransferase gene JMJD1C has tumor suppressor functions in multiple myeloma Cancer Research. 74: 5158-5158. DOI: 10.1158/1538-7445.Am2014-5158  0.373
2013 Borad MJ, Egan J, Champion M, Hunt K, McWilliams R, McCullough A, Aldrich J, Nasser S, Liang W, Barrett M, Craig D, Ramanathan R, Carpten J, Stewart AK, Bryce A. Abstract CT112: Implementation of CLIA enabled integrated whole genome (WGS)/exome (WES)/transcriptome (RNAseq) next-gen sequencing to identify therapeutically relevant targets in advanced cancer patients Molecular Cancer Therapeutics. 12. DOI: 10.1158/1535-7163.Targ-13-C66  0.433
2012 Loftus JC, Ross JT, Paquette KM, Paulino VM, Nasser S, Yang Z, Kloss J, Kim S, Berens ME, Tran NL. miRNA expression profiling in migrating glioblastoma cells: regulation of cell migration and invasion by miR-23b via targeting of Pyk2. Plos One. 7: e39818. PMID 22745829 DOI: 10.1371/Journal.Pone.0039818  0.318
2012 Nasser S, Kiefer J, Armstrong B, Berens M, Kim S. Abstract 4917: Aligning xenograft models to glioblastoma (GB) patient tumors to assess chemovulnerability of patients Cancer Research. 72: 4917-4917. DOI: 10.1158/1538-7445.Am2012-4917  0.418
2011 Nasser S, Cunliffe HE, Black MA, Kim S. Context-specific gene regulatory networks subdivide intrinsic subtypes of breast cancer. Bmc Bioinformatics. 12: S3. PMID 21489222 DOI: 10.1186/1471-2105-12-S2-S3  0.367
2011 Arora S, Ranade AR, Tran NL, Nasser S, Sridhar S, Korn RL, Ross JT, Dhruv H, Foss KM, Sibenaller Z, Ryken T, Gotway MB, Kim S, Weiss GJ. MicroRNA-328 is associated with (non-small) cell lung cancer (NSCLC) brain metastasis and mediates NSCLC migration. International Journal of Cancer. Journal International Du Cancer. 129: 2621-31. PMID 21448905 DOI: 10.1002/Ijc.25939  0.341
2011 Paquette KM, Ross JT, Kloss J, Nasser S, Yang Z, Paulino VM, Kim S, Loftus JC, Tran NL. Abstract 3994: Loss of miR-23b enhances Pyk2-induced glioma cell migration and invasion Cancer Research. 71: 3994-3994. DOI: 10.1158/1538-7445.Am2011-3994  0.312
2011 Arora S, Ranade AR, Tran NL, Nasser S, Sridhar S, Ross JTD, Dhruv H, Kim S, Weiss GJ. Abstract 127: MicroRNA-328 is associated with non-small cell lung cancer (NSCLC) brain metastasis and mediates NSCLC migration Cancer Research. 71: 127-127. DOI: 10.1158/1538-7445.Am2011-127  0.359
2011 Salhia B, Ross J, Paquette K, Fowler A, Cott CV, Metpally R, Baker A, Nasser S, Kiefer J, Ramanathan R, Resau J, Berens M, Carpten J, Tran N. Abstract B198: Integrated genomic analysis of breast cancer CNS metastasis to the CNS. Molecular Cancer Therapeutics. 10. DOI: 10.1158/1535-7163.Targ-11-B198  0.429
Show low-probability matches.